Clinical Trial Update: CCI-779 in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of temsirolimus (CCI-779) in patients with prostate cancer, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED